Biontech Se ADR
(BNTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | |
| Cash Flows From Operating Activities | |
| Net Income | -56,289 |
| Depreciation Amortization | 25,963 |
| Other Working Capital | -48,375 |
| Other Operating Activity | 9,990 |
| Operating Cash Flow | $-68,711 |
| Cash Flows From Investing Activities | |
| PPE Investments | -35,304 |
| Other Investing Activity | -43,998 |
| Investing Cash Flow | $-79,302 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | 431,274 |
| Financing Cash Flow | $431,274 |
| Exchange Rate Effect | -542 |
| Beginning Cash Position | 203,257 |
| End Cash Position | 485,976 |
| Net Cash Flow | $282,718 |
| Free Cash Flow | |
| Operating Cash Flow | -68,711 |
| Free Cash Flow | -68,711 |